Skip Navigation LinksHome > Research > National Blood Foundation > NBF Grant Recipients On The NBF Funding Program

NBF Grant Recipients On The NBF Funding Program

The NBF funding has been critical for purchasing supplies for my research over the last two years and was my main source of laboratory funding. Data generated using the NBF funding was presented in my 2009 application for an NIH/NHLBI K08 Mentored Clinical Scientist Development Award, which was scored favorably last fall and is expected to begin funding in August 2010. Thus, the NBF grant was crucial for the beginning of my journey as an independently funded investigator.

Rose Beck, MD, PhD
2008 NBF Grantee

As a tenure track junior faculty obtaining funding from NBF was a major accomplishment in an early stage of my career. Furthermore, this funding provided me with the research support needed to generate data necessary as preliminary findings for my future applications. Importantly, NBF funding gave me the confidence that I've chosen a right path for my career and, hopefully, I can become a successful physician/scientist with an impact on the lives of patients.

Peiman Hematti, MD
2007 NBF Grantee

The NBF funding has been critical to my research career. It was the first grant I was awarded, and data obtained from this research has led to a number of subsequent presentations, manuscripts, and grants (including a Fellow Research Scholar Award from the American Society of Hematology, and a K08 from the NHLBI). I cannot thank the NBF enough for providing me with the opportunity to succeed in research.

Jeanne Hendrickson, MD
2006 NBF Grantee

The funding from the National Blood Foundation came at the start of the project and was critical in growing and nurturing a new area of research that has the potential to enhance the basic science of microfluidics and the practice of clinical cell processing.

Allison Hubel, PhD
2005 NBF Grantee

Receiving the NBF grant has significantly furthered both my career and research goals. Specifically, the NBF grant provided important funding for a research project that was not yet fully developed. The NBF funding allowed continuation of the work. Our findings have led to important insights into the basic biology of embryonic stem cell differentiation, and should lead to several publications in the coming year. Most importantly, the NBF grant itself, when combined with the subsequent findings, served as the basis for a recent RO1 submission to the Developmental Biology Section of the National Institute of General Medical Sciences at the NIH. In a very material way, the NBF has allowed me to establish myself in the embryonic stem cell field at a crucial time in my career development, as a young physician scientist with an interest in both transfusion medicine and basic science.

Chance John Luckey, MD, PhD
2009 NBF Grantee

I've long held an interest in developing the practice of in utero transplantation. It has been recognized for some time that barriers exist in the fetus that limit clinically significant levels of engraftment. It has been a slow and sometimes difficult process of testing different methods that may overcome fetal transplant barriers. The financial support of NBF has helped to support my research to the point that we can now see a light at the end of the tunnel.

Marcus Muench, PhD
2006 NBF Grantee

The NBF funding provided a great opportunity for me to perform a research project which otherwise could not have been accomplished because of lack of resources. I have broadened my research field from working only on EBV previously to another Herpesvirus (HHV8). I would like to continue to expand my research to include additional members of Hepesvirus family. I achieved considerable intellectual and professional growth from working on this project, and I am most grateful for this opportunity.

Lirong Qu, MD, PhD
2007 NBF Grantee

Despite the apparent lack of progress, NBF funding has helped considerably with furthering my goals. Without this funding I would be completely reliant on the stretched research funds of our group and may not have the freedom to pursue my own interests. Since having the funding, I have also been successful in obtaining other research money for the same project, which has been allowed to continue.

Jill Storry, PhD
2006 NBF Grantee

Receiving NBF funding and successfully performing the study described in this final report has certainly increased my scientific level of working and thinking. It has subsequently led to my appointment at the Department of Pediatrics. Moving to a clinical department, in which allogeneic SCT and intensive monitoring of transplanted patients is daily routine, has offered me new possibilities to continue this interesting line of research. The preliminary results described in this final report are expected to increase my chances to receive long-term funding for performing these new studies.

Astrid van Halteren, PhD
2007 NBF Grantee

I was delighted when my NBF grant proposal was selected in 2000 and I became one of the fortunate NBF grant recipients that year. The goal of my grant proposal was to develop reagents for helping transfusion medicine professionals find compatible blood units for patients in need of transfusion. I was hoping that the studies funded by the NBF award, which was my first major funded project, would lay the groundwork to develop my own independent research program and would ultimately allow me to submit grant proposals to other funding agencies including the National Institutes of Health. I also knew that it takes a great deal of hard work from the NBF staff to raise funds and I was indebted to the various contributors that had enabled the NBF to provide grants to young investigators like myself to pursue their scientific research interests.

Being aware of the great opportunity given to me, I thus embarked on the NBF funded project which started in June 2000. With the funding I received, I hired a talented research technician, Dan Tamasauskas and with his help, we generated parts of a blood cell molecule called complement receptor 1 by molecular manipulation and showed these molecules could be used to help solve complex serological problems in the clinical setting.

Using some of the preliminary data that we thus generated, I was able to submit my first independent National Institutes of Health RO1 grant in February of 2001, which was funded, first time round, in December 2001. In the course of the studies, we also developed an animal model of ABO transfusion reactions and showed that complement receptor 1 can indeed lower the immune response in a living organism. Based on these latter data, I submitted a second proposal, this time to the American Heart Association in January of 2002, which was also funded in July 2002. Having secured funding, I was able to start my own independent group here at the New York Blood Center.

One of the most exciting aspects of doing research is the ability to explore new ideas and I was given that opportunity because of the NBF funding. As a result, my research career was transformed and I was able to establish myself as an independent scientist. I sincerely hope that the community continues to support the NBF so that young investigators like me can be give the opportunity to flourish and hopefully make contributions to the field of transfusion medicine and blood banking.

Karina Yazdanbakhsh, PhD
2000 NBF Grantee

The results of our NBF-supported research have been used as a basis for further application to the Israel Science Foundation, the US-Israel Binational Science Foundation, and the US National Blood Foundation. The NBF funding and subsequent publications have assisted in the promotion of Dr. G. Barshtein to the highest rank (A) in the Hebrew University Researchers Track. This grant also enabled the completion of the PhD degree of Dr. Alex Koshkaryev, and the M.Sc. Degree of Dr. Yuval Ramot, MD.

Saul Yedgar, PhD
2007 NBF Grantee

NBF provided me first grant in my research career. The grant served as a starting scientific support for me, as a young physician scientist, to pursue a long term career in basic and translational research focusing on the biology of normal as well as malignant hematopoiesis and stem cell biology. I greatly appreciated the support from NBF, and believe that such support is consistent with NBF's commitment to foster young scientists who have the potential of becoming outstanding independent investigators. The grant money also allows me to train a postdoctoral associate in the lab to pursue novel techniques and methodologies, such as using mouse embryonic stem cell in vitro differentiation and transplant model to study genes important for regulating hematopoiesis. These novel findings will provide invaluable information to help us understand normal process of hematopoiesis, stem cell biology, cellular and molecular mechanisms underlying leukemia development, and promote the development of animal models and techniques that can benefit the practice and outcomes of transfusion medicine as well as human cellular therapy.

Lan Zhou, MD, PhD
2006 NBF Grantee

The NBF grant I was awarded helped to encourage and make possible my efforts into developing a transfusion medicine research program, which is now independently funded by one (and likely two) NIH grants.

James Zimring, MD, PhD
2004 NBF Grantee